Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community

Am J Transplant. 2020 Nov;20(11):3123-3130. doi: 10.1111/ajt.16284. Epub 2020 Sep 27.

Abstract

Many deceased-donor and living-donor kidney transplants (KTs) rely on commercial airlines for transport. However, the coronavirus-19 pandemic has drastically impacted the commercial airline industry. To understand potential pandemic-related disruptions in the transportation network of kidneys across the United States, we used national flight data to compare scheduled flights during the pandemic vs 1-year earlier, focusing on Organ Procurement Organization (OPO) pairs between which kidneys historically most likely traveled by direct flight (High Volume by direct Air transport OPO Pairs, HVA-OPs). Across the United States, there were 39% fewer flights in April 2020 vs April 2019. Specific to the kidney transportation network, there were 65.1% fewer flights between HVA-OPs, with considerable OPO-level variation (interquartile range [IQR] 54.7%-75.3%; range 0%-100%). This translated to a drop in median number of flights between HVA-OPs from 112 flights/wk in April 2019 to 34 in April 2020 (P < .001), and a rise in wait time between scheduled flights from 1.5 hours in April 2019 (IQR 0.76-3.3) to 4.9 hours in April 2020 (IQR 2.6-11.2; P < .001). Fewer flights and longer wait times can impact logistics as well as cold ischemia time; our findings motivate an exploration of creative approaches to KT transport as the impact of this pandemic on the airline industry evolves.

Keywords: clinical research/practice; kidney disease; kidney transplantation/nephrology; quality of care/care delivery.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aircraft / statistics & numerical data*
  • COVID-19 / epidemiology*
  • Comorbidity
  • Female
  • Humans
  • Kidney Transplantation / methods*
  • Male
  • Pandemics*
  • Renal Insufficiency / epidemiology
  • Renal Insufficiency / surgery*
  • Retrospective Studies
  • SARS-CoV-2
  • Tissue Donors / supply & distribution*
  • Tissue and Organ Procurement / organization & administration*
  • United States / epidemiology